(a) Reduces the expression of oncogenes FOS, JUN, NF‐κB, and Myc, as well as cell cycle regulators CCND1, CCNE1, and CDK4/6; (b) inhibits tumor T cell and TAM auto secretion of 5‐HT signaling to promote antitumor immunity. The gene discussed is FOS; the disease is neoplasm.